BACKGROUND: Lower extremity artery disease (LE-PAD) is one of the most common manifestations of atherosclerosis, particularly in elderly patients, and it is related to a high cardiovascular risk. DESCRIPTION: It is well established that statin therapy is characterized by crucial benefits on cardiovascular system by limiting atherosclerotic progression and reducing cardiovascular events and mortality. A growing body of evidence support efficacy of statins in LE-PAD due to the ability of both reducing cardiovascular risk and improving walking distance and, hence, quality of life. Consequently, statin therapy should be considered in all LE-PAD patients and new LDL-cholesterol targets should be reached. CONCLUSIONS: Our opinion is that statin therapy remains still underutilized or with inadequate dosage, so therapy of LE-PAD patients should be improved to obtain all the demonstrated benefits of statins
Use of statins in lower extremity artery disease: a review / Gargiulo, G.; Giugliano, Giuseppe; Brevetti, L.; Sannino, A.; Schiattarella, G. G.; Serino, F.; Carbone, A.; Scudiero, F.; Ferrone, M.; Corrado, R.; Izzo, Raffaele; Chiariotti, Lorenzo; Perrino, Cinzia; Amato, Bruno; Trimarco, Bruno; Esposito, Giovanni. - In: BMC SURGERY. - ISSN 1471-2482. - ELETTRONICO. - (2012), pp. 70-74. [10.1186/1471-2482-12-S1-S15]
Use of statins in lower extremity artery disease: a review
G. Gargiulo;GIUGLIANO, GIUSEPPE;A. Sannino;G. G. Schiattarella;IZZO, RAFFAELE;CHIARIOTTI, LORENZO;PERRINO, CINZIA;AMATO, BRUNO;TRIMARCO, BRUNO;ESPOSITO, GIOVANNI
2012
Abstract
BACKGROUND: Lower extremity artery disease (LE-PAD) is one of the most common manifestations of atherosclerosis, particularly in elderly patients, and it is related to a high cardiovascular risk. DESCRIPTION: It is well established that statin therapy is characterized by crucial benefits on cardiovascular system by limiting atherosclerotic progression and reducing cardiovascular events and mortality. A growing body of evidence support efficacy of statins in LE-PAD due to the ability of both reducing cardiovascular risk and improving walking distance and, hence, quality of life. Consequently, statin therapy should be considered in all LE-PAD patients and new LDL-cholesterol targets should be reached. CONCLUSIONS: Our opinion is that statin therapy remains still underutilized or with inadequate dosage, so therapy of LE-PAD patients should be improved to obtain all the demonstrated benefits of statinsFile | Dimensione | Formato | |
---|---|---|---|
Use of statins in lower extremity artery disease- a review bmc surgery 2012.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
188.48 kB
Formato
Adobe PDF
|
188.48 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.